Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1974 4
1975 3
1976 1
1980 2
1981 2
1982 1
1984 4
1985 2
1986 2
1987 1
1988 3
1989 2
1990 3
1991 7
1992 5
1993 10
1994 6
1995 5
1996 4
1997 2
1998 5
1999 7
2000 5
2001 8
2002 5
2003 4
2005 3
2007 3
2008 1
2009 1
2010 2
2011 2
2012 2
2013 2
2014 2
2016 1
2017 2
2020 2
2021 2
2022 2
2023 1
2024 4
2025 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

132 results

Results by year

Filters applied: . Clear all
Page 1
Humoral and cell-mediated immune responses to COVID-19 vaccines up to 6 months post three-dose primary series in adults with inborn errors of immunity and their breakthrough infections.
Unninayar D, Falcone EL, Chapdelaine H, Vinh DC, Top KA, Derfalvi B, Issekutz TB, Decaluwe H, Pham-Huy A, Upton J, Betschel SD, Rubin T, Suresh S, Wright NAM, Murguía-Favela L, Kalashnikova T, Barrett L, Oldford S, Langlois MA, Arnold C, Sadarangani M, Zhang T, Ramsay T, Yazji D, Cowan J. Unninayar D, et al. Among authors: issekutz tb. Front Immunol. 2025 Jan 21;15:1501908. doi: 10.3389/fimmu.2024.1501908. eCollection 2024. Front Immunol. 2025. PMID: 39906736 Free PMC article.
Clinical exome sequencing data from patients with inborn errors of immunity: Cohort level diagnostic yield and the benefit of systematic reanalysis.
Vorsteveld EE, Van der Made CI, Smeekens SP, Schuurs-Hoeijmakers JH, Astuti G, Diepstra H, Gilissen C, Hoenselaar E, Janssen A, van Roozendaal K, Engelen JS, Steyaert W, Weiss MM, Yntema HG, Mantere T, AlZahrani MS, van Aerde K, Derfalvi B, Faqeih EA, Henriet SSV, van Hoof E, Idressi E, Issekutz TB, Jongmans MCJ, Keski-Filppula R, Krapels I, Te Loo M, Mulders-Manders CM, Ten Oever J, Potjewijd J, Sarhan NT, Slot MC, Terhal PA, Thijs H, Vandersteen A, Vanhoutte EK, van de Veerdonk F, van Well G, Netea MG; all members of the Radboud University Medical Center multidisciplinary immune-disease board; Simons A, Hoischen A. Vorsteveld EE, et al. Among authors: issekutz tb. Clin Immunol. 2024 Nov;268:110375. doi: 10.1016/j.clim.2024.110375. Epub 2024 Oct 5. Clin Immunol. 2024. PMID: 39369972 Free article.
The Role of Type III Interferons in Human Disease.
Malik AE, Issekutz TB, Derfalvi B. Malik AE, et al. Among authors: issekutz tb. Clin Invest Med. 2021 Jun 14;44(2):E5-18. doi: 10.25011/cim.v44i2.36622. Clin Invest Med. 2021. PMID: 34152702 Review.
132 results